Table 2.
Demographics and clinicopathological characteristics of the study cohort (N = 38, 100%).
| Variables | Frequency (%) |
|---|---|
| Gender | |
| Male | 17 (44.7%) |
| Female | 21 (55.2%) |
| Age group | |
| ≤ 40 years | 17 (44.7%) |
| > 40 years | 21 (55.2%) |
| Tumor type | |
| Neuroendocrine | 22 (57.8%) |
| Solid pseudopapillary | 16 (42.1%) |
| Tumor site | |
| Head | 9 (23.6%) |
| Body/tail | 12 (31.5%) |
| Specific site in pancreas unknown | 17 (44.7%) |
| T stage | |
| T1 | 14 (36.8%) |
| T2 | 6 (15.7%) |
| T3 | 14 (36.8%) |
| T4 | 4 (10.5%) |
| AJCC stage | |
| I | 19 (50%) |
| II | 13 (34.2%) |
| III | 6 (15.7%) |
| Histological differentiation | |
| Well | 25 (65.7%) |
| Moderate | 13 (34.2%) |
| Poor | 0 |
| Health status | |
| Alive | 27 (71.05%) |
| Dead | 11 (28.9%) |
| Lymphovascular invasion | |
| No | 32 (84.2) |
| Yes | 6 (15.7) |
| Perineural invasion | |
| No | 22 (57.8) |
| Yes | 16 (42.1) |
| Diabetes | |
| No | 31 (81.5) |
| Yes | 7 (18.4) |
| Smoking | |
| No | 32 (84.2) |
| Yes | 6 (15.7) |
| Chemotherapy | |
| No | 32 (84.2) |
| Yes | 6 (15.7) |